Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina

被引:0
|
作者
Liliana Bezrodnik
Andrea Gómez Raccio
Gabriela Belardinelli
Lorena Regairaz
Damacia Díaz Ballve
Gisela Seminario
Ileana Moreira
Carlos Riganti
Claudio Cantisano
Héctor Díaz
Daniela Di Giovanni
机构
[1] Inmunología,
[2] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
[3] Inmunología,undefined
[4] Hospital de Niños “Sor María Ludovica”,undefined
[5] Inmunología,undefined
[6] Hospital de Niños Pedro Elizalde,undefined
[7] Inmunología,undefined
[8] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
来源
关键词
Argentina; children; immunoglobulin therapy; intravenous; primary immunodeficiency; subcutaneous; Beriglobina P;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1216 / 1222
页数:6
相关论文
共 50 条
  • [21] FlebogammaA® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
    Ballow, Mark
    Pinciaro, Paul J.
    Craig, Timothy
    Kleiner, Gary
    Moy, James
    Ochs, Hans D.
    Sleasman, John
    Smits, William
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (06) : 583 - 589
  • [22] Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home
    Al-Saud, Bandar
    AlRumayyan, Nora
    Alfattani, Areej
    Abu Awwad, Sawsan
    Al Saud, Dema
    Mohammed, Reem
    Albuhairi, Sultan
    Elshorbagi, Sahar
    Balhareth, Sakra S.
    Al-Dhekri, Hasan
    Arnaout, Rand
    De Vol, Edward B.
    Al-Mousa, Hamoud
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1360 - 1366
  • [23] Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home
    Bandar Al-Saud
    Nora AlRumayyan
    Areej Alfattani
    Sawsan Abu Awwad
    Dema Al Saud
    Reem Mohammed
    Sultan Albuhairi
    Sahar Elshorbagi
    Sakra S. Balhareth
    Hasan Al-Dhekri
    Rand Arnaout
    Edward B. De Vol
    Hamoud Al-Mousa
    Journal of Clinical Immunology, 2023, 43 : 1360 - 1366
  • [24] Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases
    Ishiwata, Yasuyoshi
    Nagata, Masashi
    Tsuge, Kohta
    Takahashi, Hiromitsu
    Suzuki, Sayo
    Imai, Kohsuke
    Takagi, Masatoshi
    Kanegane, Hirokazu
    Morio, Tomohiro
    Yasuhara, Masato
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 327 - 331
  • [25] Efficacy and tolerability of an Argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases
    Krasovec, S.
    Ornani, A.
    Oleastro, M.
    Rosenzweig, S.
    Roy, A.
    Perez, L.
    Campos, G.
    Marin, N.
    Martinez, A.
    Mahieu, C.
    Manfredi, M. J.
    Sisti, A.
    Zelazko, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (02) : 227 - 232
  • [26] Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases
    S. Krasovec
    A. Ornani
    M. Oleastro
    S. Rosenzweig
    A. Roy
    L. Perez
    G. Campos
    N. MarÍn
    A. Martinez
    C. Mahieu
    M. J. Manfredi
    A. Sisti
    M. Zelazko
    Journal of Clinical Immunology, 2007, 27 : 227 - 232
  • [27] Inflammatory bowel diseases associated with primary immunodeficiency: a multicenter study
    Malamut, G.
    Simon, M.
    Nachury, M.
    Uzzan, M.
    Serrero, M.
    Fumery, M.
    Trang-Poisson, C.
    Zallot, C.
    Abitbol, V.
    Charbit-Henrion, F.
    Gornet, J. M.
    Picard, C.
    Cerf-Bensussan, N.
    Chaussade, S.
    Sokol, H.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I223 - I224
  • [28] Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
    H. W. Schroeder
    C. J. Dougherty
    Infection, 2012, 40 : 601 - 611
  • [29] Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
    Schroeder, H. W., Jr.
    Dougherty, C. J.
    INFECTION, 2012, 40 (06) : 601 - 611
  • [30] Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
    Jolles, S.
    Bernatowska, E.
    de Gracia, J.
    Borte, M.
    Cristea, V.
    Peter, H. H.
    Belohradsky, B. H.
    Wahn, V.
    Neufang-Hueber, J.
    Zenker, O.
    Grimbacher, B.
    CLINICAL IMMUNOLOGY, 2011, 141 (01) : 90 - 102